The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial
Purpose: Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial hemorrhage (ICH) secondary to TBI is associated with a high risk of coagulopathy which leads to increasing risk of hemorrhage growth and higher mortality rate. Therefore, antifibrinolytic agents such as tr...
Main Authors: | Abolfazl Jokar, Koorosh Ahmadi, Tayyebeh Salehi, Mahdi Sharif-Alhoseini, Vafa Rahimi-Movaghar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Chinese Journal of Traumatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1008127517300147 |
Similar Items
-
CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
by: Dewan Yashbir, et al.
Published: (2012-06-01) -
A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS])
by: Abda Mahmood, et al.
Published: (2017-07-01) -
Post-traumatic headache in patients with minimal traumatic intracranial hemorrhage after traumatic brain injury: a retrospective matched case-control study
by: Chang-Ki Hong, et al.
Published: (2017-06-01) -
The puzzle of spontaneous versus traumatic intracranial hemorrhages
by: Gabriel Alexander Quiñones-Ossa, et al.
Published: (2020-05-01) -
Early initiation of prophylactic heparin in severe traumatic brain injury is associated with accelerated improvement on brain imaging
by: Luke Kim, et al.
Published: (2014-01-01)